Christopher Morgan

Director/Board Member at

Alpha Cancer Technologies, Inc.

Commercial Services

Consumer Services

Electronic Technology

Profile

Christopher W.
Morgan is currently Director at Alpha Cancer Technologies, Inc. Formerly, Mr. Morgan was Director at Spectra7 Microsystems, Inc. from 2021 to 2025 and Partner at Skadden, Arps, Slate, Meagher & Flom LLP.
Mr. Morgan earned an MBA from the University of Toronto.

Christopher Morgan active positions

Companies	Position	Start
Alpha Cancer Technologies, Inc. Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures chemotherapeutic drugs	Director/Board Member	-

All active positions of Christopher Morgan

Former positions of Christopher Morgan

Companies	Position	End
SPECTRA7 MICROSYSTEMS INC.	Director/Board Member	28/04/2025
Skadden, Arps, Slate, Meagher & Flom LLP Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Operates as a legal firm	Corporate Officer/Principal	-

See the detail of Christopher Morgan's experience

Training of Christopher Morgan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Morgan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Skadden, Arps, Slate, Meagher & Flom LLP Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Operates as a legal firm	Commercial Services
University of Toronto University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Spectra7 Microsystems, Inc. Spectra7 Microsystems, Inc. SemiconductorsElectronic Technology Manufactures semiconductor products	Electronic Technology
Alpha Cancer Technologies, Inc. Alpha Cancer Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures chemotherapeutic drugs	Health Technology